News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Protein Polymer Technologies (PPTI) Submits 510(k) Application For Expanded Indications Of Its Embolization Products


5/11/2006 12:43:23 PM

Protein Polymer Technologies, Inc. (OTC BB: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis, announced that it has filed a 510(k) application with the U.S. Food and Drug Administration (FDA) for clearance to expand the labeled indications of Surgica's embolization products to include treatment of hypervascular tumors including uterine fibroids, liver and renal tumors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES